From USFDA
Alembic Pharmaceuticals announced that the Company has received approval from the USFDA for its Abbreviated New Drug Application for Candesartan Cilexetil Tablets, 32 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Atacand Tablets, 32 mg of AstraZeneca Pharmaceuticals LP. The drug is indicated in treatment of hypertension in adults and children and treatment of heat failure.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
